Palliative care of bone pain due to skeletal metastases: Exploring newer avenues using neutron activated 45Ca

To the best of our knowledge, this is the first study on utilization of 45CaCl2 in the context of nuclear medicine. The results obtained in this study hold promise and warrant further investigations for future translation of 45CaCl2 to the clinics, thereby potentially enabling a cost-effective approach for metastatic bone pain palliation especially in developing countries.